essential for informed consent prior to proceeding with surgical intervention.
Traditional methods of operative risk stratification include the American Society of Anesthesiologist (ASA) physical status classification and the Charlson comorbidity index (CCI). [3] [4] [5] In addition, a growing body of research has demonstrated the use of measures of frailty, including the modified frailty index (mFI), to predict postoperative morbidity and mortality for numerous surgical interventions including pancreatectomy, hepatectomy, and colorectal surgery. [6] [7] [8] Frailty is defined as decreased physiologic reserve and, therefore, increased vulnerability to disability due to inability to withstand stressors. 9 The mFI was developed specifically to measure frailty using the American College of Surgeons National Surgical Quality Improvement Project (ACS-NSQIP) dataset and consists of 11 variables measuring frailty based on the Canadian Study on Health and Aging (CSHA). 6, 10 Limited data are available evaluating the performance of the ASA classification, the CCI, and the mFI to predict postoperative outcomes among advanced cancer patients undergoing surgical intervention, particularly patients with malignant bowel obstruction.
Our objective was to compare the ASA classification, CCI, and mFI as independent predictors for postoperative outcomes among disseminated malignancy (DMa) patients undergoing surgical intervention for bowel obstruction. We were specifically interested in the ability of these measures to predict serious complications, prolonged length of stay (LOS), and 30-day mortality, as such outcomes have the potential to significantly impact terminal cancer patients' remaining quality and quantity of life. We hypothesized that higher ASA, CCI, and mFI scores would be associated with greater rates of serious morbidity, prolonged LOS, and 30-day mortality.
| METHODS
The ACS-NSQIP database was queried from January 1, 2007 to December 31, 2012. ACS-NSQIP is a national registry consisting of prospectively collected data on surgical patients from 603 NSQIPaffiliated hospitals shown to have high-reliability reporting and data quality. 11 We did not include data after 2012 due to missing data for multiple variables which are key components of the mFI and CCI.
Patients were selected based on the following three inclusion criteria: Terminology (CPT) codes. ACS-NSQIP defines DMa as "cancer that: (1) has spread to one or more sites in addition to the primary site and (2)"
the presence of such "indicates the cancer is widespread, fulminant, or near terminal." 12 Patients who underwent a hernia repair or pancreatic, hepatobiliary, or gynecological operation were excluded. We identified 1928 patients who met these specific inclusion and exclusion criteria, and we abstracted 29 patient demographic, operative, and hospital stay characteristics along with perioperative outcomes for these patients.
Our main predictor variables were ASA classification, CCI, and mFI scores. ASA classification was abstracted directly from NSQIP as reported using a scale of 1-5. 12 Four patients were classified as ASA 1
(indicative of a normal healthy patient) and were combined with ASA 2 patients (indicative of mild systemic disease) for analysis.
The CCI was calculated based on the following ACS-NSQIP variables (with assigned point values) as described previously: 13,14 age
(1 point for each decade ≥50 years), myocardial infarction (MI) within 6 months prior to surgery (1), congestive heart failure (CHF) (1), Although previous authors have divided the points for each patient by 11 to create a ratio, we chose to use whole numbers instead for simpler interpretation. For our cohort, mFI scores ranged from 0 to 9. Given that very few patients had mFI scores ≥6, we combined patients with scores ≥5 into one category for data analyses.
The primary outcomes of our analyses were 30-day serious morbidity, prolonged LOS and 30-day mortality. A secondary outcome was 30-day overall morbidity. Thirty-day serious morbidity was defined as sustaining at least one postoperative complication which required further invasive procedures (surgical, endoscopic, or radiologic), led to lasting disability, and/or was life-threatening requiring lCU level care (ie, Clavien III and IV complications). 16, 17 Serious morbidity complications included pulmonary embolism, respiratory failure, prolonged intubation, acute renal failure requiring dialysis, reoperation, stroke, cardiac arrest, and systemic shock, among others as previously described. 16, 17 Prolonged LOS was defined as a length of hospitalization ≥75th
percentile for all patients in our cohort, which was ≥20 days. 16, 18 Thirtyday mortality was defined relative to the principal operation. All patient information was de-identified and, therefore, exempt from the University of California, Davis, Institutional Review Board approval. 3 | RESULTS
| Statistical analysis

| Patient demographic, preoperative, and operative characteristics
We identified 1928 patients with DMa who underwent an abdominal operation with a principal diagnosis of bowel obstruction. Patient demographic, preoperative, and operative characteristics are presented in Table 1 . A total of 55% (n = 1063) were female with a mean age of 63 ± 13 years. Few had impaired functional status preoperatively (21.0%, n = 404). Rates of emergency operations were 34.7%
(n = 668). Few (n = 99, 6.5%) had received radiotherapy within 90 days and 34.9% (n = 534) had undergone preoperative chemotherapy Table 2 .
| Prolonged length of stay, 30-day morbidity, and mortality
Rates of 30-day overall morbidity, serious morbidity, and mortality were 35.8%, 20.4%, and 14.8%, respectively. Figures 1-3 illustrate rates of prolonged LOS, 30-day serious morbidity and 30-day mortality by ASA classification, CCI, and mFI scores. ASA classification was not a predictor of prolonged LOS, 30-day serious or overall morbidity (P > 0.05). However, as shown in Table 3 Table 3 ).
Similar to ASA and CCI, the mFI was not a significant predictor of prolonged LOS (P > 0.05). Additionally, only select mFI scores were predictors of 30-day overall and serious morbidity. Specifically, patients with scores of 1 or 4 had increased risk of overall morbidity compared to non-frail patients with an mFI of 0 (OR 1.45, 95%CI
1.09-1.93, P = 0.01 and OR 2.73, 95%CI 1.26-5.89, P = 0.01, respectively). Furthermore, as shown in Figure 2 , only patients with a score of ≥5 had an increased risk of serious morbidity compared to non-frail patients (OR 3.75, 95%CI 1.22-11.49, P = 0.02). Despite these limitations, as shown in Table 3 , mFI scores ≥1 were consistently predictive of 30-day mortality. There were no differences in AUCs for mortality between all three risk stratification methods (P > 0.05 all).
FIGURE 1
Rates of prolonged length of stay (LOS) by American Society of Anesthesiologists (ASA) classification, Charlson comorbidity index (CCI), and modified frailty index (mFI). ASA classification and the mFI were not predictors of prolonged LOS on multivariate analyses. *CCI score of 11 had decreased risk of prolonged LOS compared to CCI score of 6 (P = 0.009)
FIGURE 2
Rates of 30-day serious morbidity by American Society of Anesthesiologists (ASA) classification, Charlson comorbidity index (CCI), and modified frailty index (mFI). ASA classification and the CCI were not predictors of serious morbidity on multivariate analyses. *Patients with an mFI score of ≥5 had a greater risk of serious morbidity compared to nonfrail patients (P = 0.02)
FIGURE 3
Rates of 30-day mortality by American Society of Anesthesiologists (ASA) classification, Charlson comorbidity index (CCI), and modified frailty index (mFI). *ASA classification scores of ≥4 had greater risk of 30-day mortality compared to patients with an ASA score of 2; *CCI scores of ≥12 had a greater risk of 30-day mortality compared to patients with a CCI score of 6; and *mFI scores ≥1 had greater risk of 30-day mortality compared to nonfrail patients (P < 0.05 all)
Analyses of the individual components of the CCI and mFI to predict our primary outcome measures are presented in Table 4 . Table 5 describes risk stratification scores and patient outcomes by surgical procedure performed. There were no significant differences in ASA, CCI, or mFI score distributions by operation type, specifically for bowel resections, celiotomy/lysis of adhesions, gastrointestinal (GI bypass), and ostomy creation (P > 0.05 all). Thirty-day overall and serious morbidity was greatest for bowel resections (n = 356, 43.4%
| Risk stratification by operation type
and n = 219, 26.7%) compared to celitiomies/lyses of adhesions (n = 143, 32.5% and n = 78, 17.7%), GI bypasses (n = 81, 36.3% and n = 38, 17.0%), and ostomy creations (n = 71, 23.6% and n = 39, 12.5%; P < 0.0001 both). Rates of prolonged LOS were greatest for GI bypasses (n = 67, 30.2%), followed by bowel resections (n = 227, 27.7%), celiotomies/lyses of adhesions (n = 99, 22.6%), and ostomy creations (n = 58, 18.6%). There was no difference in rates of mortality by operation type (P = 0.14).
Multivariate analyses evaluating ASA, CCI, and mFI scores as predictors of our primary outcomes by operation type showed minimal and inconsistent predictive ability of risk stratification scores for all indices. For example, ASA scores were not predictive of serious morbidity, prolonged LOS, or 30-day mortality (P > 0.05) with one exception. For celiotomy/lysis of adhesion operations, ASA scores of 4 
| DISCUSSION
In this analysis of DMa patients undergoing all surgical interventions for bowel obstruction, ASA classification, CCI, and mFI were not consistent predictors of serious postoperative complications or prolonged LOS, but were significant predictors of 30-day mortality.
These findings were also apparent in our subgroup analyses, in which ASA classification, CCI, and mFI were inconsistent predictors of all primary endpoints when stratified by operation type. Overall, these findings were somewhat surprising, as all three risk stratification methods have previously been shown to reliably predict postoperative morbidity for various abdominal operations including colorectal surgery, pancreatic surgery, and hepatectomy. [4] [5] [6] [7] [8] Additionally, we observed limited ability of the CCI to predict 30-day mortality among DMa patients except for patients with scores ≥12 for all procedures, which is notable considering that the CCI was specifically created to predict mortality. 3 Given these unexpected findings, questions arise as to (1) bradykinesia, falls, and malignancy. 10, 16, [19] [20] [21] Excluding these variables creates a measure of frailty that emphasizes patients' accumulation of deficits, rather than reduced physiologic reserve, similar to the ASA and CCI. It is likely that accumulated deficits have minimal impact on postoperative outcomes for advanced cancer patients, in contrast to measures of decreased physiological reserve including sarcopenia, hypoalbuminemia, and poor functional status. 22 This is evident in our findings that hypoalbuminemia and impaired functional status were consistent predictors of postoperative complications and mortality.
Furthermore, limitations of the ASA classification revolve around the subjective nature of its assessment, as inter-rater reliability has been to be found to be fair to moderate. 23, 24 Consequently, there is the potential for variability in ASA scoring to impact the prognostic effectiveness of this tool.
Moreover, the limited ability of these three risk stratification methods to predict postoperative adverse events may also be secondary to the baseline elevated perioperative risk which exists for DMa patients. DMa patients may be sufficiently "frail" by definition that standard risk stratification methods offer limited additional discrimination. In fact, patients with DMa are known to have higher rates of postoperative overall and serious morbidity, prolonged LOS, and 30-day mortality compared to patients without DMa. 16 may confer an elevated risk of postoperative complications that the additional effect of other medical comorbidities, which define the ASA, CCI, and mFI, may be incremental and therefore difficult to discern.
Despite the limited ability of ASA classification, CCI, and mFI scores to predict prolonged LOS or postoperative morbidity, it is important to note that these measures were predictors of 30-day postoperative mortality in our primary analyses. Consistent with prior research, we found that impaired preoperative functional status and low albumin levels were consistent predictors for adverse post-surgical outcomes among DMa patients. 25, 26 Such findings reinforce the prognostic information that these two variables provide, especially for determining operative risk in DMa patients with bowel obstruction.
The findings of this research illustrate the need for a more refined, tailored risk stratification tool for this at-risk patient population. 
